The import of vaccines for human use to Singapore is projected to steadily increase from 2024 to 2028. In 2023, the actual import value stood at 57.392 million USD. Forecasted data reveal a consistent year-on-year growth rate: 5.5% from 2024 to 2025, 4.3% from 2025 to 2026, 4% from 2026 to 2027, and 3.8% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the five-year period is approximately 4.5%.
Future trends to watch for include:
- Innovations and advancements in vaccine technology which may alter import volumes and costs.
- Shifts in global vaccine production and distribution that could impact availability and prices.
- Policy changes and healthcare demands in Singapore, influenced by population growth and public health strategies.
- Potential global health crises that could lead to sudden spikes in vaccine imports.
- Strategic partnerships and agreements with vaccine-producing nations to ensure a steady supply.
